https://germanhealthreview.com/article/910206583-seowerk-wandelt-sich-zu-einer-spezialisierten-full-service-geo-first-agentur-mit-performance-ansatz German Health Review en PressRelease 2026-05-04T08:18:30+00:00 seowerk wandelt sich zu einer spezialisierten Full-Service-GEO-First-Agentur mit Performance-Ansatz https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24846659-geo-agentur-seowerk-die-drei-g-3596x2382.jpeg https://germanhealthreview.com/article/910200936-seowerk-transforms-into-a-specialized-full-service-geo-agency German Health Review en PressRelease 2026-05-04T07:39:14+00:00 Seowerk Transforms into a Specialized Full-Service GEO Agency https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24846640-the-managing-directors-of-the-g-3596x2382.jpeg https://germanhealthreview.com/article/910200430-comintelli-named-a-visionary-in-the-2026-gartner-magic-quadrant-for-competitive-and-market-intelligence-platforms German Health Review en PressRelease 2026-05-04T07:27:32+00:00 Comintelli Named a Visionary in the 2026 Gartner® Magic Quadrant™ for Competitive and Market Intelligence Platforms https://germanhealthreview.com/article/910242370-dr-falk-pharma-and-renexxion-announce-positive-results-on-naronapride-in-gastroparesis-from-the-global-phase-2b-move-it-trial German Health Review en PressRelease 2026-05-04T12:00:00+00:00 Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial https://ml-eu.globenewswire.com/media/7cf77d4a-25b5-4471-a282-0334907cbfbd/small/falk-logo-rgb-jpg.jpg https://germanhealthreview.com/article/910242373-cptx-to-present-preclinical-proof-of-principle-of-its-dna-based-in-vivo-car-t-platform-at-asgct-annual-meeting German Health Review en PressRelease 2026-05-04T12:00:00+00:00 CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting https://ml-eu.globenewswire.com/media/b3ec9ca7-8866-466a-9d91-09342002e341/small/cptx-logo-high-res-png.png https://germanhealthreview.com/article/910237878-inflarx-reports-favorable-reactive-metabolite-profile-for-izicopan-in-human-liver-microsomes German Health Review en PressRelease 2026-05-04T11:30:00+00:00 InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png